Fundraising Fox
/Companies
Sign in

InnovHeart

6 known investors

Find your way into InnovHeart

Sign up to see every warm intro you have to InnovHeart

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the InnovHeart team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.

HealthtechMedical Devices

Founders & leadership

DJDavid James Wilson
David James WilsonChief Executive Officer

Investors · 6

Indaco Venture Partnerslisted by Indaco Venture PartnersMilan

How we know: Indaco Venture Partners's portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

Panakes PartnersreportedMilan

How we know: prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 3

GenextraGrand PharmaleadGrand Pharmaceutical Grouplead

Funding

SEC filings, press & company announcements

$55M disclosed across 1 of 2 rounds · 2022–2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as InnovHeart.

In the news

InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System - BioSpacebiospace.com · Jan 2022InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement Systemprnewswire.com · Jan 2022

Frequently asked questions

What does InnovHeart do?
InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.
Who are InnovHeart's investors?
InnovHeart's investors include CDP Venture Capital, Indaco Venture Partners, Panakes Partners.
How much funding has InnovHeart raised?
InnovHeart has disclosed $55M raised across 1 of its 2 known rounds.